RGNX Chart
See on advanced chart >
About
Regenxbio Inc.was formed on July 16, 2008 in the state.The company is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. In AAV gene therapy, the viral genes...
Read More
- HighlightA leading clinical-stage biotechnology company that develops adeno-associated virus gene therapies to treat metabolic, neurodegenerative desease
- ExchangeNASDAQ
- Listing Date09/17/2015
- Established Date07/16/2008
- Full-time Employees401
- Address9804 Medical Center Drive Rockville Maryland 20850
- Tel1-240-5528181
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology
